View in EDS HTML Full Text PDF Full Text

The GLP-1 Receptor Agonist Dulaglutide Attenuates Hepatic Steatosis in Obesity via a Weight-Independent Mechanism.

Saved in:
Bibliographic Details
Title: The GLP-1 Receptor Agonist Dulaglutide Attenuates Hepatic Steatosis in Obesity via a Weight-Independent Mechanism.
Authors: Shantaram D; Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH., Rima XY; Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH., Bradley D; Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Pennsylvania State Health Milton S. Hershey Medical Center, Hershey, PA., Liu JZ; Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH., Wright VP; Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH., Amari A; Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH., Jalilvand A; Division of Trauma, Critical Care, and Burn, Department of Surgery, Wexner Medical Center, The Ohio State University, Columbus, OH., Rottinghaus J; Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH., Fernandes JM; Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH., Smith AJ; Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH., Middendorf D; Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH., Yearsley M; Department of Pathology, Wexner Medical Center, The Ohio State University, Columbus, OH., Roy D; Department of Neuroscience, Wexner Medical Center, The Ohio State University, Columbus, OH., Hsueh WA; Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH.
Source: Diabetes [Diabetes] 2025 Sep 01; Vol. 74 (9), pp. 1512-1524.
Publication Type: Journal Article
Journal Info: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model: Print Cited Medium: Internet ISSN: 1939-327X (Electronic) Linking ISSN: 00121797 NLM ISO Abbreviation: Diabetes Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40663700
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The GLP-1 Receptor Agonist Dulaglutide Attenuates Hepatic Steatosis in Obesity via a Weight-Independent Mechanism.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shantaram+D%22">Shantaram D</searchLink>; Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Rima+XY%22">Rima XY</searchLink>; Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Bradley+D%22">Bradley D</searchLink>; Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Pennsylvania State Health Milton S. Hershey Medical Center, Hershey, PA.<br /><searchLink fieldCode="AU" term="%22Liu+JZ%22">Liu JZ</searchLink>; Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Wright+VP%22">Wright VP</searchLink>; Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Amari+A%22">Amari A</searchLink>; Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Jalilvand+A%22">Jalilvand A</searchLink>; Division of Trauma, Critical Care, and Burn, Department of Surgery, Wexner Medical Center, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Rottinghaus+J%22">Rottinghaus J</searchLink>; Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Fernandes+JM%22">Fernandes JM</searchLink>; Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Smith+AJ%22">Smith AJ</searchLink>; Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Middendorf+D%22">Middendorf D</searchLink>; Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Yearsley+M%22">Yearsley M</searchLink>; Department of Pathology, Wexner Medical Center, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Roy+D%22">Roy D</searchLink>; Department of Neuroscience, Wexner Medical Center, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Hsueh+WA%22">Hsueh WA</searchLink>; Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372763%22">Diabetes</searchLink> [Diabetes] 2025 Sep 01; Vol. 74 (9), pp. 1512-1524.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Diabetes+Association%22">American Diabetes Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372763 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1939-327X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200121797%22">00121797 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40663700
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2337/db24-0861
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1512
    Titles:
      – TitleFull: The GLP-1 Receptor Agonist Dulaglutide Attenuates Hepatic Steatosis in Obesity via a Weight-Independent Mechanism.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shantaram D
      – PersonEntity:
          Name:
            NameFull: Rima XY
      – PersonEntity:
          Name:
            NameFull: Bradley D
      – PersonEntity:
          Name:
            NameFull: Liu JZ
      – PersonEntity:
          Name:
            NameFull: Wright VP
      – PersonEntity:
          Name:
            NameFull: Amari A
      – PersonEntity:
          Name:
            NameFull: Jalilvand A
      – PersonEntity:
          Name:
            NameFull: Rottinghaus J
      – PersonEntity:
          Name:
            NameFull: Fernandes JM
      – PersonEntity:
          Name:
            NameFull: Smith AJ
      – PersonEntity:
          Name:
            NameFull: Middendorf D
      – PersonEntity:
          Name:
            NameFull: Yearsley M
      – PersonEntity:
          Name:
            NameFull: Roy D
      – PersonEntity:
          Name:
            NameFull: Hsueh WA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2025 Sep 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1939-327X
          Numbering:
            – Type: volume
              Value: 74
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Diabetes
              Type: main
ResultId 1